Molecular Partners’ total offer size of IPO reaches CHF 106.2 million after partial exercise of IPO over-allotment option

Molecular Partners’ total offer size of IPO reaches CHF 106.2 million after partial exercise of IPO over-allotment option Zurich-Schlieren, December 5, 2014. Molecular Partners AG announces that the total offer size of the initial public offering (“IPO”) amounts to CHF 106.2 million, of which gross proceeds from the [...]

2019-10-09T16:10:37+01:00December 5th, 2014|All News, Company News, Previous Sectors|

Molecular Partners has successfully priced its IPO post re-launch and lists its shares on SIX Swiss Exchange

Molecular Partners has successfully priced its IPO post re-launch and lists its shares on SIX Swiss Exchange Zurich-Schlieren, November 4, 2014. Molecular Partners AG has successfully re-launched its Initial Public Offering (IPO). Due to strong interest and demand from both international and Swiss institutional and private investors, Molecular [...]

2019-10-09T16:05:22+01:00November 4th, 2014|All News, Company News, Previous Sectors|

Bind Therapeutics enters nanomedicine collaboration with Swiss drug giant

Bind Therapeutics enters nanomedicine collaboration with Swiss drug giant By Chris Reidy | GLOBE STAFF JUNE 19, 2014 – Bind Therapeutics Inc., a Cambridge-based nanomedicine company that is developing programmable drugs to certain types of cancer, said Thursday it has entered into a research agreement with Swiss drug [...]

2019-10-09T16:02:18+01:00June 19th, 2014|All News, Company News, Previous Sectors|

Roche and Molecular Partners enter into alliance to develop new cancer treatments Partnership will combine novel biologics (DARPins) with Roche drug-conjugate technology

Roche and Molecular Partners enter into alliance to develop new cancer treatments Partnership will combine novel biologics (DARPins) with Roche drug-conjugate technology Basel, Switzerland / Zurich-Schlieren, Switzerland, 04 December 2013. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Molecular Partners AG today announced that they have entered into a [...]

2019-10-09T16:00:03+01:00December 4th, 2013|All News, Company News, Previous Sectors|

Blackhawk Network Acquires Germany-Based Prepaid Leader Retailo as Part of Ongoing International Expansion Strategy

Blackhawk Network Acquires Germany-Based Prepaid Leader Retailo as Part of Ongoing International Expansion Strategy Deal brings Blackhawk’s retail network to over 40,000 retail locations in world’s 4th largest economy LONDON – Dec. 2, 2013 – Blackhawk Network announced that it has completed the acquisition of Germany-based Retailo AG, [...]

2019-10-09T14:12:52+01:00December 2nd, 2013|All News, Company News, Previous Sectors|

BIND Therapeutics Announces Pricing of Initial Public Offering

BIND Therapeutics Announces Pricing of Initial Public Offering CAMBRIDGE, Mass. (EON: Enhanced Online News) BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, announced today the pricing of its initial public offering of 4,700,000 shares of its common stock at a public [...]

2019-10-09T14:13:02+01:00September 19th, 2009|All News, Company News, Previous Sectors|
Go to Top